| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/12/2009 | EP2087908A1 Antibodies to opgl |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087886A1 Therapeutic agent for rheumatoid arthritis |
| 08/12/2009 | EP2086561A1 Topical formulation and uses thereof |
| 08/12/2009 | EP1682121B1 Use of crth2 antagonist compounds in therapy |
| 08/12/2009 | EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids |
| 08/12/2009 | EP1224170B1 6-position substituted indoline, production and use thereof as a medicament |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101506239A Antihuman alpha9 integrin antibody and use of the same |
| 08/12/2009 | CN101506206A Inhibitors of Akt activity |
| 08/12/2009 | CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 08/12/2009 | CN101506164A Piperidine derivatives |
| 08/12/2009 | CN101505794A scFV antibodies which pass epithelial and/or endothelial layers |
| 08/12/2009 | CN101505787A Treatment of cartilage disorders |
| 08/12/2009 | CN101505755A Agent for overcoming resistance to anti-cancer agent |
| 08/12/2009 | CN101503457A Column chromatography PEG and interferon analogue protein N-terminal site-directed coupling method and product thereof |
| 08/12/2009 | CN101502629A Chinese herbal compound preparation for treating systemic lupus erythematosus |
| 08/12/2009 | CN101502615A Plaster for traumatic injury and bone fracture |
| 08/12/2009 | CN101502610A Method for extracting veratrum alkaloid from Veratrum nigrum by supercritical carbon dioxide |
| 08/12/2009 | CN101502603A Chinese medicine for treating bone fracture |
| 08/12/2009 | CN101502598A Medicament for treating protrusion of lumber vertebral disc and method for preparing the same |
| 08/12/2009 | CN101502587A Pharmaceutical combination and preparation method thereof |
| 08/12/2009 | CN101502571A Blood circulation-promoting, antalgic and anti-inflammatory medicament as well as preparation method and use thereof |
| 08/12/2009 | CN101502563A Application of mulberry twig flavone and diphenyl ethylene extract in preparing medicament for inhibiting uric acid reabsorption transporter |
| 08/12/2009 | CN101502544A Capparis spinosa extract and capparis spinosa emulsifiable paste and method for producing the same |
| 08/12/2009 | CN101502527A Application of mulberroside in preparing medicament for inhibiting uric acid reabsorption transporter |
| 08/12/2009 | CN101502526A Application of mulberry twig flavone and diphenyl ethylene extract in preventing or treating hyperuricemia symptoms and uarthritis |
| 08/12/2009 | CN101502490A Ketoprofen bioadhesive gel microsphere and preparation method thereof |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525815C A medicinal wine capable of treating multiple diseases |
| 08/12/2009 | CN100525786C Compound milettia reticulata capsule and method for preparing the same |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525766C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 08/11/2009 | US7572825 4-(t-Butyldiphenylsiloxy)pentyl-p-toluene sulfonate; 2,2-[4-Biphenyl-5-(t-butyldiphenylsiloxy)pentyl)]-1,3-propanedithiane; osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, aseptic loosening of prosthetic implants; inflammation |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572795 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |
| 08/11/2009 | US7572765 polypeptides or fragments used for treating bone disorders such as osteoporosis |
| 08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572467 Compositions comprising organic extracts of Geum japonicum thunb var. and the use thereof |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2447614C A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/08/2009 | CA2620932A1 Use of antiresorptive compounds to prevent radiation-induced activation of osteoclasts and resulting bone loss |
| 08/06/2009 | WO2009097228A2 Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
| 08/06/2009 | WO2009096905A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009095798A2 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis |
| 08/06/2009 | WO2009064938A9 Method of treating arthritis |
| 08/06/2009 | WO2009040702A3 Pharmaceutical compositions of rhein or diacerein |
| 08/06/2009 | WO2008138131A9 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 08/06/2009 | US20090197837 Alendronate formulations, method of making and method of use thereof |
| 08/06/2009 | US20090197824 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197807 Sulphated hyaluronic acid for treating degenerative osteoarthritis |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090196904 Highly-mineralized osteogenic sponge compositions and uses thereof |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090194893 Chewable Capsule and Production Method Thereof |
| 08/06/2009 | DE102008008071A1 Injizierbare biokompatible Zusammensetzung Injectable biocompatible composition |
| 08/06/2009 | CA2712647A1 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP2084268A2 Methods and compositions for treatment of bone defects with placental cell populations |
| 08/05/2009 | EP2084183A1 Pegylated pth as pth receptor modulators and uses thereof |
| 08/05/2009 | EP2083836A1 Nutritional supplement |
| 08/05/2009 | EP2083810A2 Compositions comprising carnosic acid 12-methylether |
| 08/05/2009 | EP2083805A2 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders |
| 08/05/2009 | EP2083624A2 2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators |
| 08/05/2009 | EP1931349A4 Use of sodium channel blockers for the management of musculoskeletal pain |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1442115B1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 08/05/2009 | EP1407004B1 Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease |
| 08/05/2009 | EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 08/05/2009 | CN101501051A Amides as sphingomyeline inhibitors |
| 08/05/2009 | CN101501038A Fused [d]pyridazin-7-ones |
| 08/05/2009 | CN101500654A Compositions for the treatment of chronic degenerative inflammatory conditions |
| 08/05/2009 | CN101500608A Preventive or remedy for inflammatory disease |
| 08/05/2009 | CN101497589A Method for synthesizing 2-(3-cyano-4- isobutoxy phenyl)-4-methyl-carboxylate |
| 08/05/2009 | CN101496886A Effective powder for treating traumatic injury |
| 08/05/2009 | CN101496875A External-use medical ointment for bone fracture |
| 08/05/2009 | CN101496860A Chinese patent medicine for treating fracture |
| 08/05/2009 | CN101496852A Medicament for treating protrusion of lumbar vertebral disc and method for producing the same |